The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Flurbiprofen Axetil Market Research Report 2025
Synopsis
A precursor drug of flurbiprofen for analgesia after surgery and various cancers
Global Flurbiprofen Axetil market is projected to reach US$ 2124.2 million in 2029, increasing from US$ 1358 million in 2022, with the CAGR of 6.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Flurbiprofen Axetil market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Flurbiprofen Axetil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Tide Pharmaceutical
Guangdong Jiabo Pharmaceutical
CGE
Shanxi Pude Pharmaceuticals
Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
Mikasa Pharmaceutical Co., Ltd.
Segment by Type
Flurbiprofen Axetil Injection
Flurbiprofen Sustained Release Tablets
Flurbiprofen Gel Plaster
Segment by Application
Relieves Inflammation
Postoperative Analgesia
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Flurbiprofen Axetil report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
A precursor drug of flurbiprofen for analgesia after surgery and various cancers
Global Flurbiprofen Axetil market is projected to reach US$ 2124.2 million in 2029, increasing from US$ 1358 million in 2022, with the CAGR of 6.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Flurbiprofen Axetil market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Flurbiprofen Axetil market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Tide Pharmaceutical
Guangdong Jiabo Pharmaceutical
CGE
Shanxi Pude Pharmaceuticals
Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
Mikasa Pharmaceutical Co., Ltd.
Segment by Type
Flurbiprofen Axetil Injection
Flurbiprofen Sustained Release Tablets
Flurbiprofen Gel Plaster
Segment by Application
Relieves Inflammation
Postoperative Analgesia
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Flurbiprofen Axetil report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Flurbiprofen Axetil Market Overview
1.1 Product Overview and Scope of Flurbiprofen Axetil
1.2 Flurbiprofen Axetil Segment by Type
1.2.1 Global Flurbiprofen Axetil Market Value Comparison by Type (2023-2029)
1.2.2 Flurbiprofen Axetil Injection
1.2.3 Flurbiprofen Sustained Release Tablets
1.2.4 Flurbiprofen Gel Plaster
1.3 Flurbiprofen Axetil Segment by Application
1.3.1 Global Flurbiprofen Axetil Market Value by Application: (2023-2029)
1.3.2 Relieves Inflammation
1.3.3 Postoperative Analgesia
1.3.4 Other
1.4 Global Flurbiprofen Axetil Market Size Estimates and Forecasts
1.4.1 Global Flurbiprofen Axetil Revenue 2018-2029
1.4.2 Global Flurbiprofen Axetil Sales 2018-2029
1.4.3 Global Flurbiprofen Axetil Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Flurbiprofen Axetil Market Competition by Manufacturers
2.1 Global Flurbiprofen Axetil Sales Market Share by Manufacturers (2018-2023)
2.2 Global Flurbiprofen Axetil Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Flurbiprofen Axetil Average Price by Manufacturers (2018-2023)
2.4 Global Flurbiprofen Axetil Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Flurbiprofen Axetil, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flurbiprofen Axetil, Product Type & Application
2.7 Flurbiprofen Axetil Market Competitive Situation and Trends
2.7.1 Flurbiprofen Axetil Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Flurbiprofen Axetil Players Market Share by Revenue
2.7.3 Global Flurbiprofen Axetil Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Flurbiprofen Axetil Retrospective Market Scenario by Region
3.1 Global Flurbiprofen Axetil Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Flurbiprofen Axetil Global Flurbiprofen Axetil Sales by Region: 2018-2029
3.2.1 Global Flurbiprofen Axetil Sales by Region: 2018-2023
3.2.2 Global Flurbiprofen Axetil Sales by Region: 2024-2029
3.3 Global Flurbiprofen Axetil Global Flurbiprofen Axetil Revenue by Region: 2018-2029
3.3.1 Global Flurbiprofen Axetil Revenue by Region: 2018-2023
3.3.2 Global Flurbiprofen Axetil Revenue by Region: 2024-2029
3.4 North America Flurbiprofen Axetil Market Facts & Figures by Country
3.4.1 North America Flurbiprofen Axetil Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Flurbiprofen Axetil Sales by Country (2018-2029)
3.4.3 North America Flurbiprofen Axetil Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Flurbiprofen Axetil Market Facts & Figures by Country
3.5.1 Europe Flurbiprofen Axetil Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Flurbiprofen Axetil Sales by Country (2018-2029)
3.5.3 Europe Flurbiprofen Axetil Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flurbiprofen Axetil Market Facts & Figures by Country
3.6.1 Asia Pacific Flurbiprofen Axetil Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Flurbiprofen Axetil Sales by Country (2018-2029)
3.6.3 Asia Pacific Flurbiprofen Axetil Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Flurbiprofen Axetil Market Facts & Figures by Country
3.7.1 Latin America Flurbiprofen Axetil Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Flurbiprofen Axetil Sales by Country (2018-2029)
3.7.3 Latin America Flurbiprofen Axetil Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flurbiprofen Axetil Market Facts & Figures by Country
3.8.1 Middle East and Africa Flurbiprofen Axetil Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Flurbiprofen Axetil Sales by Country (2018-2029)
3.8.3 Middle East and Africa Flurbiprofen Axetil Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Flurbiprofen Axetil Sales by Type (2018-2029)
4.1.1 Global Flurbiprofen Axetil Sales by Type (2018-2023)
4.1.2 Global Flurbiprofen Axetil Sales by Type (2024-2029)
4.1.3 Global Flurbiprofen Axetil Sales Market Share by Type (2018-2029)
4.2 Global Flurbiprofen Axetil Revenue by Type (2018-2029)
4.2.1 Global Flurbiprofen Axetil Revenue by Type (2018-2023)
4.2.2 Global Flurbiprofen Axetil Revenue by Type (2024-2029)
4.2.3 Global Flurbiprofen Axetil Revenue Market Share by Type (2018-2029)
4.3 Global Flurbiprofen Axetil Price by Type (2018-2029)
5 Segment by Application
5.1 Global Flurbiprofen Axetil Sales by Application (2018-2029)
5.1.1 Global Flurbiprofen Axetil Sales by Application (2018-2023)
5.1.2 Global Flurbiprofen Axetil Sales by Application (2024-2029)
5.1.3 Global Flurbiprofen Axetil Sales Market Share by Application (2018-2029)
5.2 Global Flurbiprofen Axetil Revenue by Application (2018-2029)
5.2.1 Global Flurbiprofen Axetil Revenue by Application (2018-2023)
5.2.2 Global Flurbiprofen Axetil Revenue by Application (2024-2029)
5.2.3 Global Flurbiprofen Axetil Revenue Market Share by Application (2018-2029)
5.3 Global Flurbiprofen Axetil Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Tide Pharmaceutical
6.1.1 Tide Pharmaceutical Corporation Information
6.1.2 Tide Pharmaceutical Description and Business Overview
6.1.3 Tide Pharmaceutical Flurbiprofen Axetil Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Tide Pharmaceutical Flurbiprofen Axetil Product Portfolio
6.1.5 Tide Pharmaceutical Recent Developments/Updates
6.2 Guangdong Jiabo Pharmaceutical
6.2.1 Guangdong Jiabo Pharmaceutical Corporation Information
6.2.2 Guangdong Jiabo Pharmaceutical Description and Business Overview
6.2.3 Guangdong Jiabo Pharmaceutical Flurbiprofen Axetil Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Guangdong Jiabo Pharmaceutical Flurbiprofen Axetil Product Portfolio
6.2.5 Guangdong Jiabo Pharmaceutical Recent Developments/Updates
6.3 CGE
6.3.1 CGE Corporation Information
6.3.2 CGE Description and Business Overview
6.3.3 CGE Flurbiprofen Axetil Sales, Revenue and Gross Margin (2018-2023)
6.3.4 CGE Flurbiprofen Axetil Product Portfolio
6.3.5 CGE Recent Developments/Updates
6.4 Shanxi Pude Pharmaceuticals
6.4.1 Shanxi Pude Pharmaceuticals Corporation Information
6.4.2 Shanxi Pude Pharmaceuticals Description and Business Overview
6.4.3 Shanxi Pude Pharmaceuticals Flurbiprofen Axetil Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Shanxi Pude Pharmaceuticals Flurbiprofen Axetil Product Portfolio
6.4.5 Shanxi Pude Pharmaceuticals Recent Developments/Updates
6.5 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd.
6.5.1 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Corporation Information
6.5.2 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Flurbiprofen Axetil Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Flurbiprofen Axetil Product Portfolio
6.5.5 Shanghai Zhongxi Sanwei Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Mikasa Pharmaceutical Co., Ltd.
6.6.1 Mikasa Pharmaceutical Co., Ltd. Corporation Information
6.6.2 Mikasa Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Mikasa Pharmaceutical Co., Ltd. Flurbiprofen Axetil Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mikasa Pharmaceutical Co., Ltd. Flurbiprofen Axetil Product Portfolio
6.6.5 Mikasa Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flurbiprofen Axetil Industry Chain Analysis
7.2 Flurbiprofen Axetil Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flurbiprofen Axetil Production Mode & Process
7.4 Flurbiprofen Axetil Sales and Marketing
7.4.1 Flurbiprofen Axetil Sales Channels
7.4.2 Flurbiprofen Axetil Distributors
7.5 Flurbiprofen Axetil Customers
8 Flurbiprofen Axetil Market Dynamics
8.1 Flurbiprofen Axetil Industry Trends
8.2 Flurbiprofen Axetil Market Drivers
8.3 Flurbiprofen Axetil Market Challenges
8.4 Flurbiprofen Axetil Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
